Related Experiment Video
Updated: Mar 22, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media
Wilda Nurhikmah1, Yeyet Cahyati Sumirtapura1, Jessie Sofia Pamudji1
1School of Pharmacy Bandung Institute of Technology, Ganesha 10, 40132, Bandung, Indonesia.
Abstract:
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) that is widely used for the treatment of mild-to-moderate pain. Mefenamic acid belongs to the Biopharmaceutical Classification System (BCS) class II drug which has lower water solubility but high permeability. There are two different compendial methods available for dissolution tests of mefenamic acid solid dosage forms, i.e. methods of United States Pharmacopeia 37 (USP) and Pharmacopoeia of the People's Republic of China 2010 (PPRC). Indonesian Pharmacopeia V ed. (FI) adopted the USP method. On the other hand, many researches focused on the use of a 'biorelevant' medium to develop the dissolution test method. The aim of this research was to study the dissolution profile of mefenamic acid from its solid dosage forms (caplet and capsule) available in the Indonesian market with three different dissolution medium: USP, PPRC, and biorelevant fasted simulated small intestinal fluid (FaSSIF) media. The tested products consisted of the innovator's product (available only in caplet dosage form, FN caplet) and generic products (available as caplet and capsule). The dissolution test of the drug products in all dissolution media was performed in 900 mL of medium using apparatus II (paddle) at a temperature of 37°C and rotation speed of 75 rpm, except for the capsule product and for USP medium, both of which tests were done using apparatus I (basket) with rotation speed of 100 rpm. The solubility test of mefenamic acid was carried out in all media at temperature of 37°C. The result obtained from the solubility test showed that the the highest solubility of mefenamic acid was obtained in USP medium (approximately 2 mg/mL), followed by PPRC medium (about 0.5 mg/mL), and FaSSIF medium (approximately 0.06 mg/ml). In the dissolution test, percentage of drug dissolved in in the USP and PPRC media after 45 min for all products reached more than 75%, except for the PN caplet in USP medium which reached only about 44%. Meanwhile, in the biorelevant medium, the percentage of drug dissolved for all products did not exceed 16%. In all dissolution media, the capsule dosage form achieved the highest dissolution rate.
Insights
Mefenamic acid dissolution testing revealed significant differences between compendial and biorelevant media. While USP and PPRC methods showed high drug release, biorelevant fasted simulated small intestinal fluid (FaSSIF) demonstrated limited mefenamic acid solubility and dissolution.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery and Formulation
- Analytical Chemistry
Background:
- Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), is classified as a Biopharmaceutical Classification System (BCS) class II drug, characterized by low water solubility and high permeability.
- Existing compendial methods for dissolution testing, such as those from the United States Pharmacopeia (USP) and the Pharmacopoeia of the People's Republic of China (PPRC), are used for mefenamic acid solid dosage forms.
- There is growing interest in utilizing 'biorelevant' media to develop more physiologically relevant dissolution test methods.
Purpose of the Study:
- To investigate the dissolution profiles of mefenamic acid from solid dosage forms (caplets and capsules) available in the Indonesian market.
- To compare the dissolution performance of mefenamic acid in three different media: USP, PPRC, and biorelevant fasted simulated small intestinal fluid (FaSSIF).
- To assess the impact of different dissolution media on the solubility and release rate of mefenamic acid.
Main Methods:
- Dissolution tests were conducted on mefenamic acid caplets and capsules using USP, PPRC, and FaSSIF media.
- Standard dissolution apparatus (Apparatus II - paddle, or Apparatus I - basket) was employed at 37°C with specified rotation speeds.
- Solubility of mefenamic acid was determined in each of the three dissolution media at 37°C.
Main Results:
- Mefenamic acid exhibited the highest solubility in USP medium (~2 mg/mL), followed by PPRC medium (~0.5 mg/mL), and FaSSIF medium (~0.06 mg/mL).
- Dissolution in USP and PPRC media generally exceeded 75% drug release within 45 minutes for most products, with one exception (PN caplet in USP medium).
- In contrast, dissolution in the biorelevant FaSSIF medium was significantly lower, with less than 16% of the drug dissolved for all products within the tested timeframe. Capsule dosage forms consistently showed higher dissolution rates across all media.
Conclusions:
- The choice of dissolution medium significantly impacts the observed dissolution profile of mefenamic acid.
- Compendial media (USP, PPRC) may overestimate drug release compared to biorelevant FaSSIF, potentially leading to different conclusions about product performance.
- Biorelevant media like FaSSIF provide a more discriminating assessment of mefenamic acid dissolution, which is crucial given its low solubility (BCS Class II).
More Related Videos
Related Concept Videos
Drug Dissolution: Requirements and Profile Comparison
In Vitro Drug Dissolution: Compendial Testing Models I
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Influencing Drug Absorption: Drug Dissolution
Modified-Release Drug Delivery Systems: Bioavailability
In Vitro Drug Dissolution: Alternative Methods

